Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ATM | Q13315 | 1/20 | 0.58 |
| ▸ | TRPV1 | Q8NER1 | 5/20 | 0.50 |
| ▸ | CA1 | P00915 | 1/20 | 0.47 |
| ▸ | CA2 | P00918 | 1/20 | 0.47 |
| ▸ | CA5A | P35218 | 1/20 | 0.47 |
| ▸ | CA7 | P43166 | 1/20 | 0.47 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.47 |
| ▸ | HPGD | P15428 | 2/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.47 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | GAA | P10253 | 2/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.45 |
| ▸ | TSHR | P16473 | 1/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5656019 | 0.81 | ATM (0.87) | ATMTRPV1HPGDMAPK1ALDH1A1 | |
| SCHEMBL6349089 | 0.81 | ATM (0.87) | ATMTRPV1HPGDMAPK1ALDH1A1 | |
| SCHEMBL24969912 | 0.81 | ATM (0.61) | ATMTRPV1HPGDMAPK1GAA | |
| SCHEMBL7340100 | 0.81 | ITGB3 (0.63) | ALDH1A1GAATSHR | |
| SCHEMBL9830686 | 0.80 | ATM (0.65) | ATMTRPV1CA1CA2HPGD | |
| SCHEMBL9828506 | 0.80 | ATM (0.65) | ATMTRPV1HPGDMAPK1GAA | |
| SCHEMBL9829797 | 0.80 | ATM (0.69) | ATMTRPV1CA2HPGDMAPK1 | |
| SCHEMBL7598913 | 0.80 | ATM (0.60) | ATMALDH1A1 | |
| SCHEMBL4363116 | 0.80 | HDAC1 (0.64) | ATMTRPV1 | |
| SCHEMBL30783469 | 0.80 | ATM (0.60) | ATMTRPV1HPGDMAPK1GAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0988296-B1 | NAPHTHOTHIAZOLONE DERIVATIVES ACTIVE ON THE D 3 DOPAMINERGIC RECEPTOR | ZAMBON SPA (IT) | 2003-01-08 | — | — | EP | disclosed |
| EP-0781126-B1 | DERIVATIVES OF 2-AMINO-1,2,3,4-TETRAHYDRO-NAPHTHALENE ACTIVE ON THE CARDIOVASCULAR SYSTEM | ZAMBON SPA (IT) | 2001-12-12 | — | — | EP | disclosed |
| US-6232348-B1 | AGONISTS OF THE DOPAMINERGIC RECEPTORS MORE POTENT THAN DOPAMINE AND OTHER KNOWN COMPOUNDS, DEPRIVED OF INTERACTION WITH OTHER RECEPTORS AND ORALLY BIOAVAILABLE WITH A LONG TERM OF ACTION | ZAMBON GROUP S.P.A. (IT) | 2001-05-15 | — | — | US | disclosed |
| US-6107318-A | PSYCHOLOGICAL DISORDERS | ZAMBON GROUP S.P.A. (IT) | 2000-08-22 | — | — | US | disclosed |
| EP-0988296-A1 | NAPHTHOTHIAZOLONE DERIVATIVES ACTIVE ON THE D 3 DOPAMINERGIC RECEPTOR | ZAMBON GROUP S.p.A. (IT) | 2000-03-29 | — | — | EP | disclosed |
| EP-0966423-A1 | HYDROXYMETHYL DERIVATIVES OF 2-AMINO-1,2,3,4-TETRAHYDRONAPHTHALENE AS CARDIOVASCULAR AGENT | ZAMBON GROUP S.p.A. (IT) | 1999-12-29 | — | — | EP | disclosed |
| WO-1998056778-A1 | NAPHTHOTHIAZOLONE DERIVATIVES ACTIVE ON THE D3 DOPAMINERGIC RECEPTOR | ZAMBON GROUP S.P.A. (IT) | 1998-12-17 | — | — | WO | disclosed |
| WO-1998038154-A1 | HYDROXYMETHYL DERIVATIVES OF 2-AMINO-1,2,3,4-TETRAHYDRONAPHTHALENE AS CARDIOVASCULAR AGENT | ZAMBON GROUP S.P.A. (IT) | 1998-09-03 | — | — | WO | disclosed |